Informações:
Falhas:
ID
43701
Descrição
Coenzyme Q10 as a Symptomatic Treatment in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00180037
Link
https://clinicaltrials.gov/show/NCT00180037
Palavras-chave
Versões (2)
- 21/11/2016 21/11/2016 -
- 20/09/2021 20/09/2021 -
Transferido a
20 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Parkinson's Disease NCT00180037
Eligibility Parkinson's Disease NCT00180037
- StudyEvent: Eligibility
Similar models
Eligibility Parkinson's Disease NCT00180037
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Parkinson Disease
Item
parkinson's disease according to the uk brain bank criteria
boolean
C0030567 (UMLS CUI [1])
Hoehn and Yahr grades
Item
hoehn & yahr stadium ii until iii
boolean
C0451215 (UMLS CUI [1])
Gender
Item
male or female
boolean
C0079399 (UMLS CUI [1])
Age
Item
age 40 to 75 years
boolean
C0001779 (UMLS CUI [1])
Unified Parkinson's Disease Rating Scale Questionnaire
Item
updrs part iii > 15 points
boolean
C3639721 (UMLS CUI [1])
Motor fluctuations | Dyskinetic syndrome
Item
no motor fluctuations or dyskinesias
boolean
C1868976 (UMLS CUI [1])
C0013384 (UMLS CUI [2])
C0013384 (UMLS CUI [2])
Parkinson Disease Stable Duration
Item
stable parkinsonian condition for 4 weeks prior to inclusion
boolean
C0030567 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Outpatients
Item
outpatients
boolean
C0029921 (UMLS CUI [1])
Levodopa Stable
Item
patients without or with stable levodopa treatment for 4 weeks prior inclusion
boolean
C0023570 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Parkinsonian Disorders Atypical | Parkinsonian Disorders Drug-induced
Item
atypical or drug-induced parkinsonian syndromes
boolean
C0242422 (UMLS CUI [1,1])
C0205182 (UMLS CUI [1,2])
C0242422 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
C0205182 (UMLS CUI [1,2])
C0242422 (UMLS CUI [2,1])
C0458082 (UMLS CUI [2,2])
Dyskinetic syndrome | Motor fluctuations
Item
dyskinesias or motor fluctuations
boolean
C0013384 (UMLS CUI [1])
C1868976 (UMLS CUI [2])
C1868976 (UMLS CUI [2])
coenzyme Q10
Item
coenzyme q10 treatment in the past
boolean
C0041536 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Epilepsy
Item
epileptic seizures in the history
boolean
C0014544 (UMLS CUI [1])
Hypothyroidism
Item
hypothyroidism
boolean
C0020676 (UMLS CUI [1])
Medical condition Severe Interferes with Investigational New Drug
Item
severe medical conditions with interference with study drug
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0205082 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
Cholesterol Synthesis Inhibitors | Thyroid Hormones | Anti-Arrhythmia Agents | Warfarin | Metformin
Item
treatment with cse inhibitors, thyroidal hormones, antiarrhythmic drugs, warfarin, metformin
boolean
C2917205 (UMLS CUI [1])
C0040135 (UMLS CUI [2])
C0003195 (UMLS CUI [3])
C0043031 (UMLS CUI [4])
C0025598 (UMLS CUI [5])
C0040135 (UMLS CUI [2])
C0003195 (UMLS CUI [3])
C0043031 (UMLS CUI [4])
C0025598 (UMLS CUI [5])
Vitamins | Magnesium | Vitamin E | Calcium
Item
treatment or intake of vitamins, magnesium, vitamin e, calcium
boolean
C0042890 (UMLS CUI [1])
C0024467 (UMLS CUI [2])
C0042874 (UMLS CUI [3])
C0006675 (UMLS CUI [4])
C0024467 (UMLS CUI [2])
C0042874 (UMLS CUI [3])
C0006675 (UMLS CUI [4])